Join
Live feed
·
INSIDERFilingvia Quantisnow
Flexion Therapeutics, Inc. logo

SEC Form 4: Melissa Layman was granted 30,000 units of Common Stock and sold $32,931 worth of Common Stock (2,624 units at $12.55), increasing ownership by 45% to 88,376 units

ByQuantisnow·Wall Street's wire, on your screen.
FLXN· Flexion Therapeutics, Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FLXN (Flexion Therapeutics, Inc.) and more on Quantisnow.

SEC Form 4: Melissa Layman was granted 30,000 units of Common Stock and sold $32,931 worth of Common Stock (2,624 units at $12.55), increasing ownership by 45% to 88,376 units | Quantisnow